top of page

Global Covid19 - Paper on AntiViral Research - Antiviral Research, NOT IN CHINA Of chloroquine and

Global Covid19 - Paper on AntiViral Research - Antiviral Research, NOT IN CHINA Of chloroquine and COVID-19 Monday, March 9, 2020



Antiviral Research, NOT IN CHINAOf chloroquine and COVID-19Highlights • In vitro data suggest that chloroquine inhibits SARS Cov-2 replication. • In past research, chloroquine has shown in vitro activity against many different viruses, but no benefit in animal models. • Chloroquine has been proposed several times for the treatment of acute viral diseases in humans without success. • The outcomes of some current clinical trials of chloroquine in China have been announced, without access to the data. • Peer review of the results and an independent assessment of the potential benefit for patients are essential.📷







bottom of page